Kapvay ER (Clonidine HCl Bottles) 0.1mg

KAPVAY ER (clonidine hcl) 0.1mg is an extended-release prescription medication used for attention-related conditions in adults and children. This oral formulation comes in bottles of 60 tablets, designed for steady symptom management. Always follow healthcare provider guidance when using this product.

Strength

0.1mg

Pack Size

60s

Storage

15-25°

Manufacturer / TM Owner

Concordia Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

KAPVAY ER (clonidine hcl) 0.1mg is commonly used to help manage symptoms associated with attention deficit hyperactivity disorder (ADHD) in children and adults. It may also be prescribed for other conditions as determined by a healthcare professional. This extended-release version provides gradual symptom control throughout the day.

Side Effects

Users of KAPVAY ER (clonidine hcl) 0.1mg often report a calming effect that helps with focus and impulse control over time. Some people notice improved sleep patterns when taking this medication as directed. Individual responses may vary based on personal health factors.

Precautions & Warnings

Store KAPVAY ER (clonidine hcl) 0.1mg at room temperature between 15-25°C, away from moisture and direct light. Keep this medication in its original container with the lid tightly closed. Always use the child-resistant cap and store out of reach of children and pets.

Avoid Interactions

KAPVAY ER (clonidine hcl) 0.1mg may interact with other medications that affect blood pressure or the central nervous system. Alcohol and sedatives can enhance drowsiness when combined with this product. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

KAPVAY ER is an extended-release medication primarily used to manage attention-related symptoms in ADHD.

Store at room temperature (15-25°C) in the original container with the lid tightly closed.

Always consult your healthcare provider before combining with other medications to avoid potential interactions.

KAPVAY ER contains clonidine, which is not classified as a controlled substance but requires prescription.

Take the missed dose as soon as you remember, but skip it if it's almost time for the next dose.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.